PPB - Services

Complaints, Feedback and Enquiry

Pharmacy and Poisons Board Reaffirms Commitment to Safe, Quality Health Products

Uasin Gushi County, Kenya โ€“ 30th April 2025 โ€“ The Pharmacy and Poisons Board (PPB) has reaffirmed its commitment to ensuring that Kenyans access safe, quality, and effective health products and technologies (HPTs), as part of its wider agenda to enhance regulatory oversight and public health protection. Speaking at the 2nd Regulatory Authorities and Agencies (RAAs) [โ€ฆ]

Pharmacy and Poisons Board Signs FY 2024/2025 Performance Contract

Nairobi, KENYA โ€“ 9th April 2025  โ€“ The Chairperson of the Pharmacy and Poisons Board, Dr. Charles Githinji, accompanied by CEO Dr. F.M. Siyoi, signed the Boardโ€™s Performance Contract for the Financial Year 2024/2025. The ceremony was presided over by the Cabinet Secretary for Health, Hon. Aden Duale. In his remarks, the Cabinet Secretary emphasized [โ€ฆ]

Strengthening Collaboration for Safer Medical Products at Points of Entry

  Nairobi, KENYA โ€“ 10th April 2025 โ€“ The Pharmacy and Poisons Board (PPB), under the leadership of CEO Dr. F.M. Siyoi, thursday 10th April 2025  hosted representatives from the Kenya Revenue Authority (KRA), Kenya Bureau of Standards (KEBS), and KenTrade to reinforce inter-agency collaboration in the regulation of medical products at points of entry. [โ€ฆ]

๐๐ก๐š๐ซ๐ฆ๐š๐œ๐ฒ ๐š๐ง๐ ๐๐จ๐ข๐ฌ๐จ๐ง๐ฌ ๐๐จ๐š๐ซ๐ ๐„๐ง๐ ๐š๐ ๐ž๐ฌ ๐‚๐จ๐ฎ๐ง๐ญ๐ฒ ๐๐ก๐š๐ซ๐ฆ๐š๐œ๐ข๐ฌ๐ญ๐ฌ ๐ญ๐จ ๐’๐ญ๐ซ๐ž๐ง๐ ๐ญ๐ก๐ž๐ง ๐‘๐ž๐ ๐ฎ๐ฅ๐š๐ญ๐ข๐จ๐ง ๐จ๐Ÿ ๐‡๐ž๐š๐ฅ๐ญ๐ก ๐๐ซ๐จ๐๐ฎ๐œ๐ญ๐ฌ ๐š๐ง๐ ๐“๐ž๐œ๐ก๐ง๐จ๐ฅ๐จ๐ ๐ข๐ž๐ฌ

Nairobi, March 24, 2025 โ€“ The Pharmacy and Poisons Board (PPB) convened a two-day workshop with county pharmacists to strengthen the regulation of health products and technologies across Kenya. The forum aims to build collaboration and formalize a framework for joint action through a Memorandum of Understanding (MoU). Opening the workshop on behalf of CEO [โ€ฆ]

๐–๐จ๐ซ๐ฅ๐ ๐๐š๐ง๐ค ๐“๐ž๐š๐ฆ ๐„๐ง๐ ๐š๐ ๐ž๐ฌ ๐๐๐ ๐จ๐ง ๐‡๐ž๐š๐ฅ๐ญ๐ก ๐„๐ฆ๐ž๐ซ๐ ๐ž๐ง๐œ๐ฒ ๐๐ซ๐ž๐ฉ๐š๐ซ๐ž๐๐ง๐ž๐ฌ๐ฌ ๐๐ซ๐จ๐ ๐ซ๐š๐ฆ

Nairobi, Kenya โ€“ A team from the World Bank paid a courtesy call on the Chief Executive Officer of the Pharmacy and Poisons Board (PPB), Dr. F. M. Siyoi on 26th March 2025 to review the progress of the Health Emergency Preparedness, Response and Resilience Program (HEPPR). The HEPPR program, implemented through the World Bankโ€™s [โ€ฆ]

๐”๐’๐€๐ˆ๐ƒ ๐ƒ๐ข๐ซ๐ž๐œ๐ญ๐จ๐ซ ๐ƒ๐ซ. ๐Œ๐š๐ข ๐‡๐ข๐ฃ๐š๐ณ๐ข ๐„๐ง๐ ๐š๐ ๐ž๐ฌ ๐ฐ๐ข๐ญ๐ก ๐๐๐ ๐‹๐ž๐š๐๐ž๐ซ๐ฌ๐ก๐ข๐ฉ ๐จ๐ง ๐๐ฎ๐›๐ฅ๐ข๐œ ๐‡๐ž๐š๐ฅ๐ญ๐ก ๐š๐ง๐ ๐‘๐ž๐ ๐ฎ๐ฅ๐š๐ญ๐จ๐ซ๐ฒ ๐„๐ง๐ก๐š๐ง๐œ๐ž๐ฆ๐ž๐ง๐ญ๐ฌ โ€“ ๐Ÿ๐Ÿ๐ญ๐ก ๐ƒ๐ž๐œ๐ž๐ฆ๐›๐ž๐ซ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ’

๐๐š๐ข๐ซ๐จ๐›๐ข, ๐Š๐ž๐ง๐ฒ๐š  โ€“ Dr. Mai Hijazi, Director of the Office of Health Systems at USAIDโ€™s Bureau for Global Health, visited the Pharmacy and Poisons Board (PPB) on December 11, 2024, meeting with CEO Dr. F.M. Siyoi to discuss critical public health issues and the role of regulation in safeguarding Kenyansโ€™ health. During the meeting, Dr. [โ€ฆ]

๐๐๐ ๐‘๐จ๐ฅ๐ฅ๐ฌ ๐Ž๐ฎ๐ญ ๐€๐๐ฏ๐š๐ง๐œ๐ž๐ ๐๐ข๐ฅ๐ฅ๐ฌ๐œ๐š๐ง ๐“๐ž๐œ๐ก๐ง๐จ๐ฅ๐จ๐ ๐ฒ ๐ญ๐จ ๐๐จ๐จ๐ฌ๐ญ ๐Œ๐ž๐๐ข๐œ๐ข๐ง๐ž ๐๐ฎ๐š๐ฅ๐ข๐ญ๐ฒ ๐‚๐จ๐ง๐ญ๐ซ๐จ๐ฅ โ€“ 11th December 2024

Nairobi, Kenya โ€“ The Pharmacy and Poisons Board (PPB), in collaboration with Missions for Essential Drugs and Supplies (MEDS), has commenced the implementation of advanced Near Infrared Technology (NIR) known as Pillscan. Acquired from Global Health Labs USA with support from the Global Fund, this cutting-edge technology is set to enhance PPBโ€™s quality control systems [โ€ฆ]